Skip to main content
Watch Insiders
ALNYHealthcare

Alnylam Pharmaceuticals Inc (ALNY) Insider Trading

In the last 90 days, 1 Alnylam Pharmaceuticals Inc (ALNY) insider reported no open-market purchases and 1 sale totaling $398,855. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Oct 2, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 2, 2026Bryan SupranEVP, CLO and SecretarySale1,758$226.88$398,855
Jun 1, 2026David E I PyottCorporate insiderSale3,830$299.18$1,145,853

Common questions

ALNY insider trading FAQ

Are ALNY insiders buying or selling?
Over the last 90 days, ALNY insiders were net sellers, reporting $0.00 of open-market purchases and $398,855 of sales.
When was the last ALNY insider purchase?
No open-market insider purchase of Alnylam Pharmaceuticals Inc stock was reported in the last 90 days.
Where does ALNY insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Alnylam Pharmaceuticals Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.